Authors:
GAVIER B
MARTINEZGONZALEZ MA
RIEZUBOJ JI
LASARTE JJ
GARCIA N
CIVEIRA MP
PRIETO J
Citation: B. Gavier et al., VIREMIA AFTER ONE MONTH OF INTERFERON THERAPY PREDICTS TREATMENT OUTCOME IN PATIENTS WITH CHRONIC HEPATITIS-C, Gastroenterology, 113(5), 1997, pp. 1647-1653
Authors:
CASTILLACORTAZAR I
GARCIA M
MUGUERZA B
QUIROGA J
PEREZ R
SANTIDRIAN S
PRIETO J
Citation: I. Castillacortazar et al., HEPATOPROTECTIVE EFFECTS OF INSULIN-LIKE-GROWTH-FACTOR-I IN RATS WITHCARBON TETRACHLORIDE-INDUCED CIRRHOSIS, Gastroenterology, 113(5), 1997, pp. 1682-1691
Authors:
CASTILLACORTAZAR I
PRIETO J
URDANETA E
PASCUAL M
NUNEZ M
ZUDAIRE E
GARCIA M
QUIROGA J
SANTIDRIAN S
Citation: I. Castillacortazar et al., IMPAIRED INTESTINAL SUGAR-TRANSPORT IN CIRRHOTIC RATS - CORRECTION BYLOW-DOSES OF INSULIN-LIKE-GROWTH-FACTOR-I, Gastroenterology, 113(4), 1997, pp. 1180-1187
Citation: Fm. Minguez et al., EFFECTS OF ANTIFUNGAL PRETREATMENT ON THE SUSCEPTIBILITY OF CANDIDA-ALBICANS TO HUMAN-LEUKOCYTES, Chemotherapy, 43(5), 1997, pp. 346-351
Authors:
MUGUERZA B
LECAROZ C
PICARDI A
CASTILLACORTAZAR I
QUIROGA J
CEMBORAIN A
PRIETO J
SANTIDRIAN S
Citation: B. Muguerza et al., A POTENTIAL EXPERIMENTAL-MODEL FOR THE STUDY OF OSTEOPENIA IN CCL4 LIVER CIRRHOTIC RATS, Journal of physiology and biochemistry, 52(2), 1996, pp. 113-119
Citation: R. Roscam et al., ALCATEL WORLDWIDE INTELLIGENT NETWORKS - AN OVERVIEW OF SUPPLIED SYSTEMS AND SERVICES, ALCATEL COMMUNICATIONS REVIEW, (1), 1996, pp. 68
Authors:
CASTILLACORTAZAR I
URDANETA E
NUNEZ M
ZUGASTI A
MUGUERZA B
PASCUAL M
CEMBORAIN A
QUIROGA J
PRIETO J
SANTIDRIAN S
Citation: I. Castillacortazar et al., THE REDUCED INTESTINAL TRANSPORT OF D-GALACTOSE EXHIBITED BY LIVER CIRRHOTIC (LC) RATS IS NORMALIZED BY LOW-DOSES OF INSULIN-LIKE GROWTH-FACTOR (IGF-I), The FASEB journal, 10(3), 1996, pp. 2200-2200
Authors:
PRIETO I
LASARTE JJ
SAROBE P
GOLVANO J
CIVEIRA MP
GULLON A
PRIETO J
BORRASCUESTA F
Citation: I. Prieto et al., FURTHER INSIGHTS ON THE INHIBITION OF HIV TYPE-1 INFECTION IN-VITRO BY CD4-MODIFIED SYNTHETIC PEPTIDES CONTAINING PHENYLALANINE, AIDS research and human retroviruses, 12(11), 1996, pp. 1023-1030
Citation: Ml. Fanjulmoles et al., CIRCADIAN LOCOMOTOR-ACTIVITY RHYTHM DURING ONTOGENY IN CRAYFISH PROCAMBARUS-CLARKII, Chronobiology international, 13(1), 1996, pp. 15-26
Authors:
DELAPENA A
PUEYO J
HERRERO JL
BETES MT
ZUBIETA JL
SANGRO B
QUIROGA J
PRIETO J
Citation: A. Delapena et al., HYPERINTENSITY OF BASAL GANGLIA ON T1-WEIGHTED MRI IN LIVER-CIRRHOSISIS ASSOCIATED TO HYPERBILIRUBINEMIA AND PORTAL-SYSTEMIC SHUNTING, Hepatology, 24(4), 1996, pp. 1308-1308
Authors:
HERRERO JI
QUIROGA J
DELAPENA A
SANGRO B
SUBTIL JC
GARCIA N
CIENFUEGOS JA
PARDO F
HERNANDEZ JL
PRIETO J
Citation: Ji. Herrero et al., THE IMPACT OF DONOR GENDER ON THE OCCURRENCE OF CLINICALLY SIGNIFICANT RECURRENT HEPATITIS-C AFTER LIVER-TRANSPLANTATION, Hepatology, 24(4), 1996, pp. 1589-1589
Authors:
PRIETO J
YUSTE JR
BELOQUI O
CIVEIRA MP
RIEZU JI
AGUIRRE B
SANGRO B
Citation: J. Prieto et al., ANTICARDIOLIPIN ANTIBODIES IN CHRONIC HEPATITIS-C - IMPLICATION OF HEPATITIS-C VIRUS AS THE CAUSE OF THE ANTIPHOSPHOLIPID SYNDROME, Hepatology, 23(2), 1996, pp. 199-204
Authors:
LARREA E
GARCIA N
QIAN C
CIVEIRA MP
PRIETO J
Citation: E. Larrea et al., TUMOR-NECROSIS-FACTOR-ALPHA GENE-EXPRESSION AND THE RESPONSE TO INTERFERON IN CHRONIC HEPATITIS-C, Hepatology, 23(2), 1996, pp. 210-217
Authors:
KROGSGAARD K
MARCELLIN P
TREPO C
BERTHELOT P
SANCHEZTAPIAS JM
BASSENDINE M
TRAN A
OUZAN D
RINGLARSEN H
LINDBERG J
ENRIQUEZ J
BENHAMOU JP
BINDSLEV N
BERTET S
BOYER N
BRIND A
CIVEIRA MP
HOUSSET C
LUNDLAURSEN A
MAS A
POL S
PRIETO J
QUEDENS J
RAMPAL P
SCHLICHTING P
SORIANO G
SPACEY BEM
HAWLEY S
BRAND C
HOWE I
Citation: K. Krogsgaard et al., PREDNISOLONE WITHDRAWAL THERAPY ENHANCES THE EFFECT OF HUMAN LYMPHOBLASTOID INTERFERON IN CHRONIC HEPATITIS-B, Journal of hepatology, 25(6), 1996, pp. 803-813
Authors:
SAROBE P
JAUREGUI JI
LASARTE JJ
GARCIA N
CIVEIRA MP
BORRASCUESTA F
PRIETO J
Citation: P. Sarobe et al., PRODUCTION OF INTERLEUKIN-2 IN RESPONSE TO SYNTHETIC PEPTIDES FROM HEPATITIS-C VIRUS E1 PROTEIN IN PATIENTS WITH CHRONIC HEPATITIS-C - RELATIONSHIP WITH THE RESPONSE TO INTERFERON TREATMENT, Journal of hepatology, 25(1), 1996, pp. 1-9
Authors:
SIMMONDS P
MELLOR J
CRAXI A
SANCHEZTAPIAS JM
ALBERTI A
PRIETO J
COLOMBO M
RUMI MG
LOIACANO O
AMPURDANESMINGALL S
FORNSBERNHARDT X
CHEMELLO L
CIVEIRA MP
FROST C
DUSHEIKO G
Citation: P. Simmonds et al., EPIDEMIOLOGIC, CLINICAL AND THERAPEUTIC ASSOCIATIONS OF HEPATITIS-C TYPES IN WESTERN-EUROPEAN PATIENTS, Journal of hepatology, 24(5), 1996, pp. 517-524
Citation: S. Borrego et al., 2 ADDITIONAL ANLL CASES WITH CHROMOSOME-3 REARRANGEMENTS INVOLVING BANDS Q21 AND Q26, Cancer genetics and cytogenetics, 88(1), 1996, pp. 90-91
Authors:
SOPENA B
MARTINEZVAZQUEZ C
FERNANDEZRODRIGUEZ CM
DELAFUENTE J
RIVERA A
RODRIGUEZ M
GOMEZ MC
PRIETO J
Citation: B. Sopena et al., SERUM ANGIOTENSIN-CONVERTING ENZYME AND C4 PROTEIN OF COMPLEMENT AS ACOMBINED DIAGNOSTIC INDEX IN ALCOHOLIC LIVER-DISEASE, Liver, 16(5), 1996, pp. 303-308
Authors:
BALCABAO IP
AGUILAR L
MARTIN M
GARCIA Y
DALRE R
PRIETO J
Citation: Ip. Balcabao et al., ACTIVITIES AGAINST STREPTOCOCCUS-PNEUMONIAE OF AMOXICILLIN AND CEFOTAXIME AT PHYSIOLOGICAL CONCENTRATIONS - IN-VITRO PHARMACODYNAMIC SIMULATION, Antimicrobial agents and chemotherapy, 40(12), 1996, pp. 2904-2906
Authors:
AGUILAR L
BALCABAO IP
SALVA P
MARTIN M
COSTA J
PRIETO J
DALRE R
Citation: L. Aguilar et al., EX-VIVO ANTIBACTERIAL PROPERTIES OF RUFLOXACIN COMPARED WITH THOSE OFNORFLOXACIN IN A STUDY WITH HEALTHY-VOLUNTEERS, Antimicrobial agents and chemotherapy, 40(1), 1996, pp. 17-21
Authors:
MINGUEZ F
GARCIA MT
LIMA JE
LLORENTE MT
PRIETO J
Citation: F. Minguez et al., POSTANTIFUNGAL EFFECT AND EFFECTS OF LOW CONCENTRATIONS OF AMPHOTERICIN-B AND FLUCONAZOLE ON PREVIOUSLY TREATED CANDIDA-ALBICANS, Scandinavian journal of infectious diseases, 28(5), 1996, pp. 503-506
Authors:
PRIETO J
RIOS E
PARRADO A
MARTIN A
DEBLAS JM
RODRIGUEZ JM
Citation: J. Prieto et al., LEUKEMIA OF NATURAL-KILLER-CELL LARGE GRANULAR LYMPHOCYTE TYPE WITH HLA-DR(-)CD16(-)CD56(BRIGHT+) PHENOTYPE, Journal of Clinical Pathology, 49(12), 1996, pp. 1011-1013